Gordan Lauc, PhD
Co-Founder & Chief Scientific Officer, GlycanAge · GlycanAge
Glycobiology scientist whose IgG glycan research underpins GlycanAge's biological-age test
About
Gordan Lauc, PhD is GlycanAge's Co-Founder and Chief Scientific Officer and the scientist behind the IgG glycan biology the company commercializes. He is a University of Zagreb professor, founder and CEO of Genos Ltd., and co-director of the Human Glycome Project. His work connects IgG glycosylation patterns with chronic inflammation, immune aging, and biological-age estimation, giving GlycanAge its scientific foundation.
What to Know
Signature approach
Lauc's role is methodology and scientific validation. His Zagreb group produced large-scale work on the plasma glycome, the human IgG glycome, and genetic drivers of glycosylation, with the 2014 Krištić et al. biological-age paper serving as a core bridge into GlycanAge's consumer test. At GlycanAge, that research becomes a practical assay for immune-aging trend tracking.
What sets them apart
- Deep glycomics record. Google Scholar listed roughly 21,000 citations, h-index 77, and i10-index 280 at capture.
- Genos founder. Genos developed the high-throughput IgG glycomics assay behind the product.
- Human Glycome Project leadership. Lauc initiated the project in 2017 and serves as one of its co-directors.
- Academic recognition. His public bios list Johns Hopkins Society of Scholars induction and visiting professorships at Johns Hopkins, University of Edinburgh, and Edith Cowan.
Affiliations
Thought Leadership
Publications
- Glycans are a novel biomarker of chronological and biological ages · Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 2014
- Immunoglobulin G glycosylation in aging and diseases · Cellular Immunology, 2018
- Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers · PLOS Genetics, 2013
- High throughput isolation and glycosylation analysis of IgG — variability and heritability of the IgG glycome in three isolated human populations · Molecular & Cellular Proteomics, 2011
- Connecting genetic risk to disease end points through the human blood plasma proteome · Nature Communications, 2017
- Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans · Glycobiology, 2010
Media Appearances
- Prof. Gordan Lauc: The Human Glycome Project · YouTube (Gordan Lauc channel)
- Biomarker & Aging Clock Development (with Vadim Gladyshev, Harvard) · Foresight Institute · 2021-06-14
- Glycoproteins and longevity: an interview with Professor Lauc · Expert Opinion on Therapeutic Targets (Taylor & Francis) · 2024
Notable Collaborators
- Tim D. Spector, MD · IgG glycomics co-research; King's College London / TwinsUK; fellow GlycanAge SAB member
- Vlatka Zoldoš, PhD · Epigenetic regulation of glycosylation; University of Zagreb; fellow GlycanAge SAB member
- Manfred Wuhrer, PhD · Glycomics analytics; Leiden University Medical Center
- Cristina Menni, PhD · Glycan biological-age co-author (Krištić et al. 2014); King's College London
- Jim Wilson, PhD · Population glycomics; University of Edinburgh, Usher Institute
Other specialists at GlycanAge
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.